hualanbio.comCrawled Nov 17, 2026
Hualan Biological Vaccine Co. reports **CNY 1.2 billion in revenue** for 2025, marking a **6.62% year-on-year increase**. The company’s net profit attributable to shareholders declines **10.99% year-on-year** to **CNY 183 million**, despite revenue growth. The report highlights a shift in financial performance, with revenue rising while profitability weakens after accounting for non-recurring adjustments.
Russia’s **Sputnik V** vaccine developer partners with **Hualan Biological Bacterin** to manufacture the Covid-19 vaccine in China. The agreement aims to expand production capacity and distribution of the vaccine, leveraging Hualan’s local infrastructure. Both companies will collaborate on regulatory approvals and supply chain logistics for the Asian market.
China created three times more new billionaires than the U.S. in the past year, driven by wealth generated in pharmaceuticals and online entertainment sectors. The Hurun Report highlights this disparity, reflecting shifting global economic trends. New fortunes in these industries underscore China’s expanding influence in high-growth markets.
China secures WHO approval for its domestically produced flu vaccine, reinforcing its position as a key global vaccine manufacturer. The move follows China’s rapid expansion in biopharmaceutical production, competing directly with India in supplying vaccines to low- and middle-income countries. The WHO endorsement covers the vaccine’s safety, efficacy, and quality standards for international distribution.
Hualan Bio secures WHO prequalification for its split virion, inactivated influenza vaccine, marking China’s first influenza vaccine to meet global standards. The vaccine is now included in the UN’s procurement plan, enabling supply to international markets. Flu remains a critical infectious disease with severe global health impacts.

Hualan Biological Engineering is a biotechnology company that researches, develops, produces, and sells blood products, vaccines, and recombinant proteins.